# US 8,277,649 B2 · Membranes and associated methods for purification of antibodies

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,277,649 B2
- Document ID: US8277649B2
- Status: Granted
- Kind: B2
- Application number: 12/636,833
- Filed: 2009-12-14
- Published: 2011-06-16
- Granted: 2012-10-02
- Earliest claimed: 2009-12-14
- Assignees: General Electric Company
- Inventors: Patrick Roland Lucien Malenfant; Cathryn Ellen Olsen; Vincent Francis Pizzi; Gary William Yeager; Robert Scott Duthie; Per Ola Lind; Stina Elisabeth Hallgren; Annika Morrison
- Web page: https://patentgrep.com/patent/US8277649B2

## CPC

- B01D 15/3847: {Multimodal interactions}
- B01D 15/1896: {Membrane chromatography or membrane adsorbers}
- B01J 20/28097: {being coated, filled or plugged with specific compounds}
- B01J 20/3282: {Crosslinked polymers}
- B01J 41/20: Anion exchangers for chromatographic processes
- C07K 1/165: {mixed-mode chromatography}
- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- G01N 33/6854: {Immunoglobulins}
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The invention relates to a device for separating unwanted compounds from an antibody containing biological sample. The device comprises a porous support and a polymeric resin disposed within the pores of the porous support. The device may further comprise a viral clearance membrane upstream or downstream from the polymeric resin. Methods of use are also provided.

## Claims

### Claim 1

A device for separating one or more unwanted compounds from an antibody containing biological sample, said device comprising:
a porous support; and
a polymeric resin disposed within the pores of the porous support wherein the polymeric resin comprises structural units derived from:
a vinyl crosslinker; and
an aromatic monomer comprising a quaternary ammonium group and at least two ring structures.

### Claim 2 (depends on 1)

The device of claim 1, wherein the aromatic monomer having a structural unit derived from Formula I, Formula II, Formula III, or a combination thereof;
wherein R1 and R2 are independently a hydrogen, a C1-C20 alkyl, a C1-C20 substituted alkyl, an aryl, a substituted aryl, or a combination thereof, and m and n are independently integers between 1 and 5;
R3 and R4 are independently a hydrogen, a C1-C20 alkyl, a C1-C20 substituted alkyl, a benzyl or a combination thereof; and
wherein the polymeric resin is capable of selectively retaining one or more unwanted compounds present in the biological sample through a multi-modal interaction.

### Claim 3 (depends on 2)

The device of claim 2, wherein R3 comprises structural units derived from Formula IV
wherein R5 and R6 are independently a hydrogen, a C1-C20 alkyl, a C1-C20 substituted alkyl, an aryl, a substituted aryl, or a combination thereof, and m and n are independently integers between 1 and 5.

### Claim 4 (depends on 2)

The device of claim 2, wherein the polymeric resin further comprises structural units derived from Formula V
wherein Z is NH or O;
R7 is hydrogen or methyl, a C1-C5 alkyl, a substituted alkyl, or a combination thereof; and
n is an integer between 1 and 5.

### Claim 5 (depends on 2)

The device of claim 2, wherein the vinyl crosslinker comprises N′,N″-methylenebisacrylamide.

### Claim 6 (depends on 2)

The device of claim 2, wherein the multi-modal interaction comprises at least two of hydrogen bonding, ionic, electrostatic, hydrophobic, Van der Waals, or dipole-dipole interactions.

### Claim 7 (depends on 2)

The device of claim 2, wherein the porous support is selected from polysulfones, polyethersulfones, expanded polytetrafluoroethylene (e-PTFE), polyvinylidenefluoride (PVDF), polyphenyleneoxides, polycarbonates, polyesters, cellulose, or cellulose derivatives.

### Claim 8 (depends on 2)

The device of claim 2, wherein the porous support has a pore size diameter ranging from about 0.1 microns to about 10 microns.

### Claim 9 (depends on 2)

The device of claim 2, wherein the porous support has a pore size diameter ranging from about 2 microns to about 5 microns.

### Claim 10 (depends on 2)

The device of claim 2, wherein the porous support is a membrane, a web, a filter, a fiber, or a mesh.

### Claim 11 (depends on 2)

The device of claim 2, wherein the unwanted compounds comprise aggregated proteins or peptides, misfolded proteins or peptides, host cell proteins, nucleic acids, endotoxins, or a combination thereof.

### Claim 12 (depends on 11)

The device of claim 11, wherein the aggregated proteins comprise aggregated antibodies.

### Claim 13 (depends on 2)

The device of claim 2, further comprising a viral clearance membrane capable of removing virus and positioned upstream or downstream of the porous support.

### Claim 14 (depends on 13)

The device of claim 13, wherein the viral clearance membrane is positioned downstream of the porous support and wherein the device is capable of improving the capacity of the viral clearance membrane by at least 10 L/m2 as compared to an equivalent free standing viral clearance membrane.

### Claim 15 (depends on 14)

The device of claim 14, wherein the polymeric resin further comprises structural units derived from Formula V
wherein Z is NH or O;
R7 is hydrogen or methyl, a C1-C5 alkyl, a substituted alkyl, or a combination thereof; and
n is an integer between 1 and 5.

### Claim 16 (depends on 2)

The device of claim 2, wherein the device is in the form of a chromatographic chamber, tubular column, cartridge, syringe filter, manifold, multi-well plate, monoliths, filters, membranes, capillaries, microfluidic chips, a pleated cartridge or capsule, a cassette, a spiral filter, or a hollow fiber.

### Claim 17 (depends on 16)

The device of claim 16 wherein the device is capable of being sterilized.
